|1.||Landoni, Giovanni: 9 articles (03/2015 - 06/2005)|
|2.||Bove, Tiziana: 8 articles (03/2015 - 10/2004)|
|3.||Zangrillo, Alberto: 6 articles (12/2014 - 06/2005)|
|4.||Tumlin, James A: 5 articles (12/2009 - 11/2003)|
|5.||Bellomo, Rinaldo: 4 articles (03/2015 - 11/2005)|
|6.||Morelli, Andrea: 4 articles (12/2013 - 12/2003)|
|7.||Ricci, Zaccaria: 4 articles (01/2011 - 11/2005)|
|8.||Guarracino, Fabio: 3 articles (12/2014 - 06/2012)|
|9.||Biondi-Zoccai, Giuseppe G L: 3 articles (06/2012 - 01/2007)|
|10.||Mizzi, A: 3 articles (01/2010 - 06/2008)|
|1.||Hypertension (High Blood Pressure)
09/01/1999 - "These results demonstrate that fenoldopam is effective in reducing blood pressure of patients with mild-to-moderate hypertension at doses as low as 0.04 microg/kg/min, is well tolerated at doses up to 0.8 microg/kg/min, maintains most of its antihypertensive efficacy throughout 48 h of continuous, constant rate infusion, and produces neither prolonged pharmacodynamic effects nor rebound hypertension when discontinued. "
08/01/1995 - "Fenoldopam, a selective post-synaptic dopaminergic receptor (DA1) has been shown to be effective in treating severe hypertension with a lower incidence of side effects than SNP. "
09/01/1993 - "To examine the safety and efficacy of intravenous fenoldopam as compared to placebo for the treatment of postoperative hypertension. "
05/01/1990 - "To evaluate the acute BP response to iv fenoldopam mesylate (FNP), 14 patients with severe hypertension (diastolic BP 120 to 170 mm Hg) were studied in an open-label trial. "
01/01/1986 - "Six patients with essential hypertension were entered into a dose-ranging study and received either placebo, 25, 50 or 100 mg fenoldopam. "
05/29/1991 - "Fenoldopam is a selective DA1-adrenoceptor agonist found to be effective in heart failure. "
04/01/1989 - "Fenoldopam mesylate (FM) is a dopaminergic vasodilator with demonstrated efficacy and a favourable safety profile in hypertensive and congestive heart failure patients. "
04/01/1991 - "Eighteen patients with New York Heart Association class III congestive heart failure were given single 100 mg oral doses of fenoldopam with food or fasting in a random-order single-blind crossover trial. "
05/01/2005 - "First experience with intra-renal fenoldopam in a patient with heart failure."
01/01/2003 - "Potentially, the pharmacologic properties of fenoldopam could be successfully exploited in patients undergoing medical or surgical treatment of end-stage heart failure. "
|3.||Acute Kidney Injury (Acute Renal Failure)
02/01/2008 - "To determine the efficacy of fenoldopam in the prevention of acute renal failure, the authors performed a systematic review of randomized, controlled trials and propensity-matched studies in patients undergoing cardiovascular surgery. "
11/01/2005 - "Accordingly, we sought to determine the safety and efficacy of fenoldopam for the prevention of acute renal failure in septic patients. "
06/01/2012 - "Because at present no pharmacologic prevention or treatment of acute kidney injury seems to be available, the authors updated a meta-analysis to investigate the effects of fenoldopam in reducing acute kidney injury in patients undergoing cardiac surgery, focusing on randomized placebo-controlled studies only. "
06/01/2012 - "Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials."
02/01/2008 - "Four unblinded reviewers selected controlled trials that used fenoldopam in the prevention or treatment of acute renal failure in cardiovascular surgery. "
|4.||Renal Insufficiency (Renal Failure)
12/01/2004 - "Recently, studies have been initiated to evaluate the potential of a selective dopamine-1 receptor agonist (fenoldopam) in ameliorating radiocontrast-induced renal failure. "
09/01/1999 - "These findings will be useful in designing future studies exploring the role of fenoldopam in preventing or treating renal failure in patients who are not hypertensive."
02/01/2006 - "We present a case of averted CIN after multivessel coronary intervention in a diabetic patient with severe renal insufficiency, potentially due to bilateral renal arterial infusion of fenoldopam. "
11/01/2005 - "In patients with renal insufficiency, local renal infusion of fenoldopam resulted in an approximately 50% increase in renal artery velocities without substantial blood pressure reduction compared to IV fenoldopam."
07/01/2005 - "In animals with spontaneous or drug-induced renal failure, fenoldopam improves renal function. "
|5.||Critical Illness (Critically Ill)
02/01/2009 - "On the other hand, although additional studies may be warranted, fenoldopam may appear to be a likely candidate for the prevention of AKI, particularly in critically ill patients, if the positive results obtained in some recent studies are confirmed. "
05/01/2015 - "The medical records of 62 critically ill dogs and cats with AKI that received fenoldopam were reviewed. "
08/01/2011 - "Fenoldopam in critically ill patients with early renal dysfunction. "
01/01/2009 - "Fenoldopam has been used to protect renal function in critically ill patients and in those undergoing major surgery, where a possible damage of kidney is expected. "
07/01/2008 - "Fenoldopam increases urine output in select critically ill pediatric patients without requiring escalation of inotropic support. "
|2.||Nitroprusside (Sodium Nitroprusside)
|10.||Vasodilator Agents (Vasodilators)
|1.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)
|4.||Renal Replacement Therapy (Therapies, Renal Replacement)
|5.||Cardiopulmonary Bypass (Heart-Lung Bypass)